SANTHERA Trademark

Trademark Overview

On Wednesday, October 19, 2022, a trademark application was filed for SANTHERA with the United States Patent and Trademark Office. The USPTO has given the SANTHERA trademark a serial number of 97977473. The federal status of this trademark filing is REGISTERED as of Tuesday, April 9, 2024. This trademark is owned by Santhera Pharmaceuticals (Schweiz) AG. The SANTHERA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neuromuscular diseases, but not in the field of oncology and rheumatoid arthritis
santhera

General Information

Serial Number97977473
Word MarkSANTHERA
Filing DateWednesday, October 19, 2022
Status700 - REGISTERED
Status DateTuesday, April 9, 2024
Registration Number7357364
Registration DateTuesday, April 9, 2024
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 4, 2023

Trademark Statements

Description of MarkThe mark consists of the word "santhera" appearing in lower case lettering with two arched lines appearing alongside and to the left of the word.
Goods and ServicesPharmaceutical preparations for the treatment of neuromuscular diseases, but not in the field of oncology and rheumatoid arthritis
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 3, 2022
Primary Code005
First Use Anywhere DateThursday, June 22, 2023
First Use In Commerce DateThursday, June 22, 2023

Trademark Owner History

Party NameSanthera Pharmaceuticals (Schweiz) AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPratteln 4133
CH
Party NameSanthera Pharmaceuticals (Schweiz) AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPratteln 4133
CH
Party NameSanthera Pharmaceuticals (Schweiz) AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPratteln 4133
CH

Trademark Events

Event DateEvent Description
Tuesday, April 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, March 8, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, March 7, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, February 16, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, February 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 15, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 30, 2024USE AMENDMENT FILED
Tuesday, January 30, 2024SOU EXTENSION 1 GRANTED
Tuesday, January 30, 2024SOU EXTENSION 1 FILED
Thursday, February 15, 2024DIVISIONAL PROCESSING COMPLETE
Tuesday, January 30, 2024DIVISIONAL REQUEST RECEIVED
Tuesday, January 30, 2024TEAS REQUEST TO DIVIDE RECEIVED
Monday, February 12, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 30, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, August 29, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 4, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 14, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 24, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 24, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 24, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 9, 2023NON-FINAL ACTION E-MAILED
Thursday, March 9, 2023NON-FINAL ACTION WRITTEN
Thursday, March 2, 2023ASSIGNED TO EXAMINER
Thursday, October 27, 2022TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, October 27, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, November 4, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, November 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 22, 2022NEW APPLICATION ENTERED

Related Keywords

santhera oncology rheumatoid arthritis field diseases preparations treatment neuromuscular pharmaceutical